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Abstract 
 
At the Freiburger Materialforschungszentrum we have developed a new process (3D-
BioplottingTM) that permits most kind of polymers and biopolymers to be used in 3D scaffold 
design, including hydrogels (e.g. collagen, agar), polymer melts (e.g. PLLA, PGA, PCl) and two-
component systems (e.g. chitosan, fibrin). Cells can be incorporated within the construction 
process, making this an ideal Rapid Prototyping technique for Organ Printing. Tailor-made 
biodegradable soft or hard scaffolds can so be fabricated in a short time using individual 
computer-tomography data from the patient. In-vitro tests showed promising results and in-vivo 
experiments are now under observation. 
 
Introduction 
 
With an increase of computer power during the last years, new ways of creating prototypes have 
increased in importance, leaving behind the times where prototypes had to be created by hand. 
3D construction software, denominated Computer Assisted Design (CAD), can shape an idea as a 
virtual model. The main application of Rapid Prototyping is to aid the visualization of a 3D 
structure (Concept Modeling[1, 2]). With increasing demand for customized parts, the construction 
of 3D objects to aid the fabrication of machine parts, for example in the creation of molds, has 
gained in importance (Rapid Tooling[3, 4]).Today, with improving mechanical properties and 
decreasing production time, “ready for use” parts can be made using Rapid Prototyping 
techniques to create working models (Functional Modeling[5]).A more recent application for 
Rapid Prototyping techniques lies in the medical field (Tissue Engineering). Rapid Prototyping 
has started to be tested for the construction of titanium plates[6], drug releasing systems[7] and 
support structures for bone and nerve defects[8]. 
 
A great number of different  Rapid Prototyping techniques have emerged for solid free-form 
fabrication  during the last years[9-12]. These techniques can be distinguished by the materials used 
to build the layers of the object as well as the method of hardening. The material used to build 
each layer can be in the form of a foil, a powder, a slurry or a liquid film. The hardening of the 
object can be achieved by means of temperature changes, solvents, light emission or chemical 
reactions. 
 
The main techniques are 3D Dispensing, Selective Laser Sintering (SLS), Laminated Object 
Manufactering (LOM), Stereolithography (SLA), 3D Printing and Direct Write/Direct Printing. 
All these techniques are essentially restricted to the type of monomer or polymer it can use, and 
usually have only one or two methods of hardening. Most conventional techniques do not permit 
handling of a wide range of bioactive components which are temperature sensisitive and require 
exclusively non-toxic chemicals. 
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At the Freiburger Materials Research Center we have developed a new technique of 3D 
dispensing as a new tool for bioactive polymer processing (3D-BioplottingTM that allows the use 
of a large variety of materials, including a wide range of biopolymers and bioactive components,  
as well as a wide range of solidification  methods for Rapid Prototyping purposes[13]. 
 
3D-BioplottingTM 
 
This new technique, 3D-BioplottingTM, uses a pressure-controlled dispenser movable in all three 
dimensions. This way, 3D objects can be built, as typical of Rapid Prototyping techniques, layer 
by layer. Each layer is composed of single strands, which orientation can be varied for each layer. 
By setting a certain distance between the strands, porous structures can be built.  
 
 
 
Figure 1 (left): Schematics of the 3D-BioplottingTM process, building of the first layer 
Figure 2 (right): Design of a porous 3D scaffold made through 3D-BioplottingTM 
 
The surface and surroundings onto which the object is built (plot medium) defines the 
solidification method used. Whereas high-temperature polymer melts can be plotted on a glass 
plate using air or inert gases, many other materials will need certain substances to increase the 
solidification speed. A certain liquid plot medium, matching densities with those of the plotting 
materials, can also be chosen to provide a buoyancy to the plotted layers, so that soft strands will 
remain in the correct position instead of sacking due to gravitational force. This makes this 
technique the only, that can produce 3D hydrogel scaffolds in a direct plotting process, without 
the use of moulds. 
 
Figure 3: Vertical cut of plotted polyurethane scaffolds. The left scaffold was plotted in air, while 
the right one was plotted in a plott medium (water). 
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Figure 4: The 3D-Bioplotter at the Freiburg Materials Research Center, constructed by 
Envisiontec GmbH 
 
We have used 3D-BioplottingTM to create scaffolds made out of polymer melts, ceramics, 
monomers and even hydrogels[14]. The hardening methods available to this technique are 
temperature changes, evaporation of solvents and chemical bonding of monomers and polymers. 
 
Materials 
Selective 
Laser 
Sintering 
Stereo-
lithography 
3D 
Printing 
Direct 
Printing 
3D 
Dispensing 
Laminated 
Object 
Manufacturing 
Metals + - + - (+) + 
Ceramics + + + - + + 
Polymers + + + + + + 
Glas (+) - - - (+) - 
Paper - - - - - + 
Wax (+) - - + + - 
Hydrogels - (+) - - + - 
Hydrogels + 
proteins/cells - - - - (+) - 
Table 1: Materials used with different Rapid Prototyping techniques (+ = known application, - = 
not known, (+) = theoreticaly possible, but no application is known) 
 
Our main interest lies presently in the field of Tissue Engineering. Using computer tomograhy 
data from a patient, a support structure for a defect can be modelled by means of CAD software 
and then a tailor-made 3D object fabricated using biocompatible or biodegradable materials[15-17]. 
A decrease in the duration of self-regeneration is beeing tested by cultivating cells from the 
patient onto the scaffold in-vitro. This will also reduce the risc of rejection. 
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Drugs can be added to the material, which will be released in-vivo to promote the self-
regeneration process or reduce the risc of infection[18].  
 
 
Figure 5: Schematics to the process of creating a scaffold out of data from a patient, cultivating 
cells onto the scaffold and the growing of new tissue after implantation. 
 
Scaffold design 
 
The design of the scaffold is chosen accordingly to the needs of the medical application, being an 
important factor in the mechanical properties of the object. Blocks of material have several 
disadvantages, namely more material on the site which can, during degradation, provoque an 
infection and lead to slower regeneration time. A porous structure has much more advantages, the 
surface is much larger, allowing a better controlled degradation of the polymer; cells have more 
place to grow, allowing a larger concentration of cells per volume. Additionally, the flow of 
nutrient media is permitted through the gaps between the strands. 
 
While a large variety of designs are allowed for the interior layout of the scaffold[19, 20], we have 
found that a non-woven cross design has an adequate porosity while having an excellent 
structural stability. Using this non-woven design, changes in the strand thickness and distance 
between strands can be adjusted to each particular applicaton. For example, thicker strands with 
medium sized gaps are best for bone replacement, while thin strands with small gaps between 
them are needed for nerve regeneration. 
 
We have tested the compressive strength of round PLGA scaffolds (5 mm high, 14 mm diameter) 
with different gaps between strands. Surprisingly, only few of the scaffolds actually break. After 
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a certain pressure is applied, the layers start to collapse, the sooner the higher the distance 
between strands. Most scaffolds end up more flat and wide, but retaining the porous scaffold 
structure.  
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Figure 6: Compressive strength of PLGA scaffolds with different distance between strands 
 
Cell cultivation on 3D scaffolds 
 
On some RP applications, like nerve regeneration or bone defect support, cells can be cultivated 
on the scaffold to decrease the duration of self-regeneration. Because we use biocompatible 
materials and biopolymers, the question of the compatibility of the materials used and the cells 
does not arrise. More important is the question of cell adhesion. Many biocompatible polymers 
(eg. polycaprolactone) are hydrophobic, meaning cells will not adhere to the scaffold. 
 
If a hydophobic polymer has to be used, a plasma sterilisation will create hydrophilic groups on 
the surface of the polymer. The polymer surface is modified to have a better adhesion having a 
positive effect on growth (Figure 7). Another method to have cell growth on hydrophobic 3D 
scaffolds is obtained by coating of the scaffold with other materials. We have found collagen to 
be an excellent coating candidate. 
 
The design of the scaffold has also a great impact on cell growth. Very narrow gaps between 
strands will not permit the flow of nutrient media to the interior of the scaffold, the structure 
behaves similarly to a compact 3D block of material. A compromise between biological and 
mechanical properties has to be found for each application (Figure 8). 
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Figure 7: Cell growth on two similar scaffols using different sterilitazion methods. TCPS = no 
scaffold 
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Figure 8: Cell growth of 3D PLGA scaffolds using different distances between strands. TCPS = 
no scaffold (the numbers indicate cell growth during the second week with respect to that of the 
first week) 
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Plotting Hydrogels 
 
One of the challenges of Rapid Pototyping is the fabrication of 3D constructs made out of 
hydrogels. Few results have been achieved in this area, most use moulds or support structures to 
create collagen and other hydrogel scaffolds[21].  
Hydrogels have a great potencial in biomedical applications using Rapid Prototyping, soft tissue 
implants could be tailor made to each patient. 3D objects like ears and noses, as well as nerves 
and arteries could be fabricated with similar mechanical properties to the original parts. The 
addition of cells to the material previous to the plotting process would allow creating scaffolds 
with certain types of cells placed in predeterminated positions. 
 
With our technique, 3D BioplottingTM, plotting of hydrogels is possible. Scaffolds of collagen, 
chitosan, alginic acid, fibrin and agar-agar have already been successfully plotted. The structural 
design of the scaffolds can be varied like for the scaffolds using harder materials.  
 
1 cm 
    
1 cm  
 
Figure 9: 3D scaffolds made of collagen 
 
Conclusion 
 
We have developed a new technique of biofunctional Rapid Prototyping, which we refer to as 
3D-BioplottingTM and apply for Tissue Engineering. Using this method, 3D scaffolds can be 
made out of a large variety of materials, incuding polymers, ceramics and hydrogels. The 3D 
scaffolds, which can be tailor-made from CT data from the patient, have a porous interior design, 
allowing the flow of nutrient media and the cultivations of cells in the scaffold. Different 
materials have been sucessfully plotted and many of these allow the growth of cells on the 
surface. The design of the scaffolds is being optimized to increase the cell growth on them and 
the mechanical properties of the different designs are beeing investigated. These advantages give 
3D-BioplottingTM a great potential in the field of desktop manufactering for medical applications. 
 
Outlook 
 
Our main goal is the possibility of plotting a scaffold with cells inside of the material. This would 
allow the plotting of one scaffold with several cell types on it, an important step to Organ 
Printing. Our first tests have shown that plotting with cells is possible using our 
technique.Presently we are investigating the bone regeneration on sheep using hydroxy apatite, 
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PLGA and hydrogel scaffolds. Bone and bone precursor cells have been cultivated on the 
scaffolds and results of this experiment should be available towards the end of the year. 
 
 
Figure 10: Our main goal: Organ Printing 
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Chemicals Used 
 
- PLGA, Boehringer Ingelheim, Resomer LG 824 
- Hydroxy apatite, Typ SF mikrofeines Pulver C13-09, Chemische Fabrik Budenheim, 
Mainz, Germany 
- Glutardialdehyde, M = 100,12 h/ml, Fluka 49629, 50% in water 
- Collagen, extracted from bovine tendons 
- Polyvinylalcohol, M = 145 000, Clariant GmbH, Frankfurt, Germany, Mowiol 28-99 
- Acetic acid, Merck, Germany 
- EZ4U, Biomedical, Austria 
- PBS, PAA, Austria 
 
Plotting of Materials 
 
3D-Plotting of PLGA 
The Resomer LG 824 was purchased as a white powder from Boehringer Ingelheim. This powder 
was filled into a glass syringe and heated to melting point. A slow degradation of the polymer 
during the plotting process could be seen in the gradual change of the color of the polymer from 
white to yellow. 
During the plotting process, a reduction of the viscosity also takes place due to degradation, for 
this reason only small amounts of the polymer were filled into the syringe each time. Used 
syringes were cleaned with dichloromethane before being refilled, to remove all rests of 
degradated PLA, or new syringes were used. 
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3D-Plotting of hydroxy apatite with Polyvinylalcohol 
A very fine hydroxy apatite with particle sizes ranging between 1 and 10 µm was sieved through 
a 50 µm sieve on a sieving machine (Retsch, Haan, Germany - Model AS 200 control) producing 
a powder without larger agregates. A 10 % solution of polyvinylalcohol was made by dissolving 
the polymere in boiling water. 37,5 g of hydroxy apatite powder were mixed in 62,5 g of the 
polyvinylalcohol solution and stired firmly for 20 minutes. A white paste with large aggregates is 
created, which can be pressed through a 100 µm sieve. The sieved paste was filled in a PE 
syringe for the plotting process. 
After plotting, the scaffolds were kept on the plotting surface in a freezer at -15 °C for 2 hours. 
The frozen scaffolds were freeze-dried (B. Braun Biotech, Melsung, Germany – Christ, Model 
Alpha 2) for 2 days using 0.05 mbar and -20 °C. Afterwards, the dried scaffolds were inserted in 
an oven (Nabertherm, Lilienthal, Germany – Model HT04/17). The oven was slowly heated to 
350 °C using a heating rate of 25 K/h. After 5 hours at 350 °C, the temperature was raised to 
1150 °C using a heating rate of 100 K/h, at which the scaffolds were sintered for 12 hours. The 
oven was cooled slowly at a rate of 50 K/h to room temperature, to avoid cracking of the ceramic 
scaffolds. 
 
3D-Plotting of Collagen 
Collagen was extracted from bovine tendons. The collagen was dissolved in 0.5 M acetic acid, 
the inhomogenous solution was grinded. The hydrogel was precipitated in a 5% NaCl solution, 
filtered and dissolved once more. The solution was filtered through a 1 mm sieve to remove 
unsoluble collagen and then filled into dialysis tubes, which were kept in destilled water. The 
water was exchanged every 6 hours for two days. After dialysis the collagen/water mixture was 
frozen in a -70 °C freezer for 3 hours, after which they were freeze-dried for 1 day at 0.001 mbar. 
This fine collagen was grinded and then solved in 0.5 M acetic acid, to produce a 3% mixture. 
The collagen was plotted into ethanol, the ethanol was discarded after plotting and glutaraldehyde 
added to crosslink collagen. The scaffolds were afterwards washed three times with destilled 
water. 
 
Seeding of the Scaffolds 
The plotted scaffolds were sterilized using plasma sterilization (STERRAD 100S), after which 
they were washed 5 times using PBS (once per hour) and 2 times with nutrient media (once every 
24 hours). 1*106 cells and nutrient media were added and cultivated for 7 days at 37 °C under a 
5% CO2 atmosphere. The nutrient media was exchanged every two days. Before measurement, 
the scaffolds were moved to another well plate, so cells on the plate were not measured. 
 
EZ4U-test 
The substrate is first dissolved in 2,5 ml activator solution at 37 °C, coloring the solution yellow. 
Per well, 25 µl of the substrate is added to 200 µl cell culture, after which these solutions are 
incubated for 5 hours at 37 °C. After incubation, the plate is shaken on the reader (Anthos Reader 
2001) and the absorpion at 450 nm (492 nm) against 620 nm is measured. The absorpion of a 
blank value is deducted from the measured values. 
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